Identification of prognostic and therapeutic biomarkers in type 2 papillary renal cell carcinoma.
Yue WangXi TianShu-Xuan ZhuWen-Hao XuAihetaimujiang AnwaierJia-Qi SuHua-Lei GanYuan-Yuan QuJian-Yuan ZhaoHai-Liang ZhangDing-Wei YePublished in: World journal of surgical oncology (2023)
TPX2 was a prognostic and therapeutic biomarker in PRCC2. Higher abundance of tumor infiltrating M1 macrophage was significantly associated with worse overall survival in PRCC2. mTOR inhibitors may have good efficacy in patients with high-risk PRCC2.